Rakovina on $500B AI Investment Impacting Healthcare
January 24, 2025
Rakovina Therapeutics Inc. a biopharmaceutical company at the forefront of AI-driven drug discovery, yesterday commented on the announcement of a $500 billion private-sector investment into